Assignee
TOPOTARGET UK LTD
GB·20 granted patents·2 pending applications·227 citations·filing 2000–2019
Top patents by PatentIndex Score
22 records- 0193US6888027B2Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2001·Granted May 3, 2005·65 cites·63 claims
- 0292US7557140B2Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2008·Granted Jul 7, 2009·19 cites·24 claims
- 0392US7407988B2Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2006·Granted Aug 5, 2008·17 cites·22 claims
- 0491US6960685B2Carbamic acid compounds comprising an ether linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2001·Granted Nov 1, 2005·66 cites·69 claims
- 0588US7183298B2Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2004·Granted Feb 27, 2007·27 cites·124 claims
- 0683US7981895B2Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2008·Granted Jul 19, 2011·6 cites·64 claims
- 0782US7880020B2Carbamic acid compounds comprising an amide linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2009·Granted Feb 1, 2011·5 cites·49 claims
- 0879US7569724B2Carbamic acid compounds comprising an amide linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2001·Granted Aug 4, 2009·12 cites·93 claims
- 0970US7629343B2Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2003·Granted Dec 8, 2009·4 cites·86 claims
- 1068US7652036B2Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2004·Granted Jan 26, 2010·4 cites·38 claims
- 1166US10799469B2Combination therapies using HDAC inhibitorsTOPOTARGET UK LTD·Filed 2019·Granted Oct 13, 2020·0 cites·2 claims
- 1265US10285959B2Combination therapies using HDAC inhibitorsTOPOTARGET UK LTD·Filed 2014·Granted May 14, 2019·0 cites·1 claims
- 1360US7465719B2Carbamic acid compounds comprising an ester or ketone linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2004·Granted Dec 16, 2008·2 cites·53 claims
- 1459US9603926B2Histone deacetylase (HDAC) inhibitors for the treatment of cancerTOPOTARGET UK LTD·Filed 2014·Granted Mar 28, 2017·0 cites·24 claims
- 1558US2008213399A1Combination Therapies Using Hdac InhibitorsTOPOTARGET UK LTD·Filed 2006·Application pending·0 cites
- 1655US2018271852A1Histone Deacetylase (hdac) Inhibitors For The Treatment Of CancerTOPOTARGET UK LTD·Filed 2018·Application pending·0 cites
- 1754US9980957B2Histone deacetylase (HDAC) inhibitors for the treatment of cancerTOPOTARGET UK LTD·Filed 2017·Granted May 29, 2018·0 cites·11 claims
- 1853US9856211B2Pharmaceutical formulations of HDAC inhibitorsTOPOTARGET UK LTD·Filed 2014·Granted Jan 2, 2018·0 cites·20 claims
- 1950US9957227B2Pharmaceutical formulations of HDAC inhibitorsTOPOTARGET UK LTD·Filed 2017·Granted May 1, 2018·0 cites·23 claims
- 2046US6841385B2Transcription factor E2F DNA-binding domain inhibitor peptides and their useTOPOTARGET UK LTD·Filed 2001·Granted Jan 11, 2005·0 cites·16 claims
- 2145US7160677B1Transcription factor DP-1TOPOTARGET UK LTD·Filed 2000·Granted Jan 9, 2007·0 cites·14 claims
- 2245US7012128B2Interaction between cyclin D1 and steroid receptor co-activators and uses thereof in assaysTOPOTARGET UK LTD·Filed 2001·Granted Mar 14, 2006·0 cites·5 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →